Lawrence Knopf - 10 Feb 2022 Form 4 Insider Report for SQZ Biotechnologies Co (SQZB)

Role
General Counsel
Signature
/s/ Lawrence J. Knopf
Issuer symbol
SQZB
Transactions as of
10 Feb 2022
Transactions value $
$0
Form type
4
Filing time
15 Feb 2022, 16:15:31 UTC
Previous filing
04 Jan 2022
Next filing
05 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SQZB Stock Option Award $0 +97K $0.00 97K 10 Feb 2022 Common Stock 97K $6.57 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable as to 25% of the underlying securities on February 10, 2023 and in 36 substantially equal monthly installments thereafter.